Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc., trading under the ticker PWUP on Nasdaq, is a biopharmaceutical company that resulted from the business combination of Power Up Acquisition Corp, a blank-check vehicle that completed its IPO in 2021 with a focus on the life sciences and healthcare sector. The company filed its annual 10-K report with the SEC on March 11, 2024, reflecting its status as a post-combination operating entity in the drug development space. The SPAC was sponsored by Power Up Acquisition LLC. For complete filing histories, sponsor backgrounds, deal timelines, and real-time SPAC intelligence on PWUP and the broader market, sign up for full data access at SpacDesk.